These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19962811)

  • 1. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
    Su L; Fan X; Zheng L; Zheng J
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
    Liu Y; Liu D; Wang Y; Zhang W; Zhao F
    J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.
    Lee CH; Chen SG
    Br J Plast Surg; 2005 Dec; 58(8):1073-8. PubMed ID: 16055097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol sclerotherapy of peripheral venous malformations.
    Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
    Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
    Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
    Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
    Andreisek G; Nanz D; Weishaupt D; Pfammatter T
    J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous treatment of lymphatic malformations.
    Shiels WE; Kang DR; Murakami JW; Hogan MJ; Wiet GJ
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):219-24. PubMed ID: 19643255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Superselective ethanol endovascular therapy under digital subtraction angiography for craniofacial arteriovenous malformations].
    Jin YB; Lin XX; Hu XJ; Chen H; Ma G; Li W; Fan XD; Wang W
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 Nov; 25(6):406-11. PubMed ID: 20209926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
    Kishi K; Morita N; Terada T; Sato M
    Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
    Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
    J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of venous malformations: first experience with a new sclerosing agent--a multicenter study.
    Schumacher M; Dupuy P; Bartoli JM; Ernemann U; Herbreteau D; Ghienne C; Guibaud L; Loose DA; Mattassi R; Petit P; Rössler JK; Stillo F; Weber J
    Eur J Radiol; 2011 Dec; 80(3):e366-72. PubMed ID: 21458186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerotherapy of voluminous venous malformation in head and neck with absolute ethanol under digital subtraction angiography guidance.
    Wang YA; Zheng JW; Zhu HG; Ye WM; He Y; Zhang ZY
    Phlebology; 2010 Jun; 25(3):138-44. PubMed ID: 20483863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital subtraction angiography (DSA) guided sequential sclerotherapy for maxillofacial vein malformation.
    Meng J; Zhuang QW; Gu QP; Zhang J; Li ZP; Si YM
    Eur Rev Med Pharmacol Sci; 2014; 18(12):1709-12. PubMed ID: 24992611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations.
    Li L; Zeng XQ; Li YH
    AJR Am J Roentgenol; 2010 May; 194(5):W439-44. PubMed ID: 20410391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
    Jain R; Bandhu S; Sawhney S; Mittal R
    J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
    Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
    J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.